08/14/2025
8:00 AM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/06/2025
4:04 PM | Appajosyula Sireesh (Reporting)
Hillstream BioPharma (Issuer)
Tharimmune, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/06/2025
4:06 PM | Parikh Sanam (Reporting)
Hillstream BioPharma (Issuer)
Tharimmune, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/28/2025
8:26 AM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form 424B5 | |
07/28/2025
8:29 AM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/25/2025
4:09 PM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form 424B5 | |
07/11/2025
3:30 PM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
07/09/2025
11:15 PM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form EFFECT | |
07/07/2025
5:41 PM | Anderson Kelly (Reporting)
Hillstream BioPharma (Issuer)
Tharimmune, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2025
3:15 PM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
06/24/2025
3:15 PM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for HILS and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Hillstream BioPharma and its competitors with MarketBeat's FREE daily newsletter. |
06/23/2025
8:29 PM | Gravitas Capital LP (Reporting)
Hillstream BioPharma (Issuer)
Tharimmune, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2025
6:31 PM | Appajosyula Sireesh (Reporting)
Hillstream BioPharma (Issuer)
Tharimmune, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2025
6:34 PM | Parikh Sanam (Reporting)
Hillstream BioPharma (Issuer)
Tharimmune, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2025
5:15 AM | Gravitas Capital LP (Filed by)
Hillstream BioPharma (Subject)
Tharimmune, Inc. (Subject)
| Form SCHEDULE 13D | |
06/20/2025
5:05 AM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/11/2025
4:29 PM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/10/2025
3:39 PM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/23/2025
1:31 PM | GSB Holdings, Inc. (Filed by)
Hillstream BioPharma (Subject)
Tharimmune, Inc. (Subject)
| Form SCHEDULE 13G | |
05/12/2025
7:00 AM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/01/2025
9:28 AM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form ARS | |
04/30/2025
4:15 PM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form DEFA14A | |
04/30/2025
4:00 PM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form DEF 14A | |
04/28/2025
4:26 PM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/25/2025
6:35 AM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/10/2025
3:15 PM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/04/2025
4:15 PM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/27/2025
6:00 PM | Kim Dong (Reporting)
Hillstream BioPharma (Issuer)
Tharimmune, Inc. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
03/25/2025
7:12 PM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
01/14/2025
3:47 PM | MILBY RANDY (Reporting)
Hillstream BioPharma (Issuer)
Tharimmune, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/14/2025
3:38 PM | Appajosyula Sireesh (Reporting)
Hillstream BioPharma (Issuer)
Tharimmune, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/30/2024
3:15 PM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form 424B3 | |
12/26/2024
11:15 PM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form EFFECT | |
12/20/2024
7:00 PM | MILBY RANDY (Reporting)
Hillstream BioPharma (Issuer)
Tharimmune, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2024
3:15 PM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
12/17/2024
3:30 PM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form D
Notice of Exempt Offering of Securities | |
12/06/2024
4:25 PM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/02/2024
3:00 PM | Parikh Sanam (Reporting)
Hillstream BioPharma (Issuer)
Tharimmune, Inc. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
11/21/2024
3:51 PM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2024
4:06 PM | Appajosyula Sireesh (Reporting)
Hillstream BioPharma (Issuer)
Tharimmune, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/07/2024
4:22 PM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
Alex’s “Next Magnificent Seven” stocks (Ad) The original “Magnificent Seven” turned $7K into $1.18 million.
Now, Alex Green has identified AI’s Next Magnificent Seven—seven stocks he believes could deliver similar gains in under six years. His full breakdown is now live. Watch the “Next Magnificent Seven” presentation here |
10/10/2024
3:15 PM | MILBY RANDY (Reporting)
Hillstream BioPharma (Issuer)
Tharimmune, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/09/2024
8:58 AM | Appajosyula Sireesh (Reporting)
Hillstream BioPharma (Issuer)
Tharimmune, Inc. (Issuer)
| Form 4/A | |
10/08/2024
3:10 PM | Appajosyula Sireesh (Reporting)
Hillstream BioPharma (Issuer)
Tharimmune, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/30/2024
9:00 AM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/16/2024
8:06 AM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
MarketBeat All Access